Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BLOCK COPD
NCT02587351Phase 3Terminated
- Sponsor
- University of Minnesota
- Start
- May 2016
- Primary completion
- Sep 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of metoprolol in chronic obstructive pulmonary disease (COPD), sponsored by University of Minnesota. Started May 2016; status: terminated.
02
Drugs
metoprolol
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT02587351.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02587351.